11-2136949-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000612.6(IGF2):​c.-7+1280A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.682 in 152,024 control chromosomes in the GnomAD database, including 36,089 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 36089 hom., cov: 34)

Consequence

IGF2
NM_000612.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.544

Publications

16 publications found
Variant links:
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.829 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000612.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IGF2
NM_000612.6
MANE Select
c.-7+1280A>G
intron
N/ANP_000603.1P01344-1
IGF2
NM_001127598.3
c.163-1420A>G
intron
N/ANP_001121070.1P01344-3
IGF2
NM_001007139.6
c.-6-1420A>G
intron
N/ANP_001007140.2P01344-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IGF2
ENST00000416167.7
TSL:1 MANE Select
c.-7+1280A>G
intron
N/AENSP00000414497.2P01344-1
IGF2
ENST00000434045.6
TSL:1
c.163-1420A>G
intron
N/AENSP00000391826.2P01344-3
IGF2
ENST00000381392.5
TSL:1
c.-7+239A>G
intron
N/AENSP00000370799.1P01344-2

Frequencies

GnomAD3 genomes
AF:
0.681
AC:
103524
AN:
151906
Hom.:
36047
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.836
Gnomad AMI
AF:
0.561
Gnomad AMR
AF:
0.592
Gnomad ASJ
AF:
0.639
Gnomad EAS
AF:
0.704
Gnomad SAS
AF:
0.678
Gnomad FIN
AF:
0.589
Gnomad MID
AF:
0.672
Gnomad NFE
AF:
0.624
Gnomad OTH
AF:
0.686
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.682
AC:
103614
AN:
152024
Hom.:
36089
Cov.:
34
AF XY:
0.676
AC XY:
50247
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.836
AC:
34709
AN:
41516
American (AMR)
AF:
0.591
AC:
9038
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
2217
AN:
3472
East Asian (EAS)
AF:
0.703
AC:
3617
AN:
5142
South Asian (SAS)
AF:
0.677
AC:
3265
AN:
4820
European-Finnish (FIN)
AF:
0.589
AC:
6203
AN:
10530
Middle Eastern (MID)
AF:
0.675
AC:
197
AN:
292
European-Non Finnish (NFE)
AF:
0.624
AC:
42404
AN:
67938
Other (OTH)
AF:
0.686
AC:
1452
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1714
3428
5141
6855
8569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
824
1648
2472
3296
4120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.636
Hom.:
45977
Bravo
AF:
0.691
Asia WGS
AF:
0.693
AC:
2409
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
7.1
DANN
Benign
0.61
PhyloP100
-0.54
PromoterAI
-0.011
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213216; hg19: chr11-2158179; API